These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7647028)

  • 1. Nicorandil safety in the long-term treatment of coronary heart disease.
    Witchitz S; Darmon JY
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():237-43. PubMed ID: 7647028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
    Roland E
    Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
    Hanai Y; Mita M; Hishinuma S; Shoji M
    Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiischemic effects of nicorandil during coronary angioplasty in humans.
    Saito S; Mizumura T; Takayama T; Honye J; Fukui T; Kamata T; Moriuchi M; Hibiya K; Tamura Y; Ozawa Y
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():257-63. PubMed ID: 7647030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nicorandil and atenolol in stable angina pectoris.
    Hughes LO; Rose EL; Lahiri A; Raftery EB
    Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
    Aizawa Y; Uchiyama H; Yamaura M; Nakayama T; Arita M
    J Electrocardiol; 1998 Apr; 31(2):117-23. PubMed ID: 9588657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M; Landzberg BR; Frishman WH
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of vasospastic angina--role of nicorandil.
    Kaski JC
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():221-7. PubMed ID: 7647026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers.
    Wolf DL; Ferry JJ; Hearron AE; Froeschke MO; Luderer JR
    Eur J Clin Pharmacol; 1993; 44(1):27-33. PubMed ID: 8436151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
    Araki H; Hayata N; Matsuguchi T; Nakamura M
    Clin Ther; 1987; 9(2):174-82. PubMed ID: 2952276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans.
    Giles TD; Pina IL; Quiroz AC; Roffidal L; Zaleski R; Porter RS; Karalis DG; Mohrland JS; Wolf DL; Hearron AE
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):572-8. PubMed ID: 1280713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study.
    Cheng J; Qiu L; Zhang Z; Li N; Shu H; Xiao Z; Zhou N
    J Cardiovasc Pharmacol Ther; 2023; 28():10742484231197559. PubMed ID: 37661662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicorandil on kinetics of oxygen uptake at the onset of exercise in patients with coronary artery disease.
    Koike A; Hiroe M; Yajima T; Adachi H; Shimizu N; Kano H; Sugimoto K; Miyahara Y; Korenaga M; Marumo F
    Am J Cardiol; 1995 Sep; 76(7):449-52. PubMed ID: 7653442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.